Quentin Philippot

14PUBLICATIONS
546CO-AUTHORS
Infectious agentsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NeonatologyInnate immunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 22, 2026
Good? A very long COVID-19.

|Oct 01, 2024
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.

Jérémie Rosain, Tom Le Voyer, Xian Liu

|Jan 09, 2024
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.

Paul Bastard, Adrian Gervais, Tom Le Voyer

|Jan 04, 2024
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.

Paul Bastard, Adrian Gervais, Maki Taniguchi

|Jun 22, 2023
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients.

Adrian Gervais, Francesca Rovida, Maria Antonietta Avanzini

Pageof 3